Well Lead(SH:603309)2021-10-21 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥291,979,078, a decrease of 0.40% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was ¥35,220,905.72, down 17.09% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥34,217,697.38, a decrease of 15.62% compared to the previous year[3]. - Basic earnings per share for Q3 2021 was ¥0.14, a decrease of 12.50% compared to the same period last year[4]. - Total revenue for the first three quarters of 2021 was ¥765,048,329.27, a decrease of 9.1% compared to ¥841,988,142.63 in the same period of 2020[17]. - Net profit for Q3 2021 was ¥88,422,616.59, down 39.1% from ¥145,087,876.27 in Q3 2020[19]. - Operating profit for Q3 2021 was ¥108,506,266.34, compared to ¥180,532,918.03 in Q3 2020, reflecting a decline of 40%[18]. - The total comprehensive income attributable to the parent company for Q3 2021 was ¥81,760,323.34, a decrease from ¥139,561,345.90 in Q3 2020, representing a decline of approximately 41.5%[20]. - Basic and diluted earnings per share for Q3 2021 were both ¥0.31, down from ¥0.54 in Q3 2020, indicating a decrease of about 42.6%[20]. Cash Flow and Liquidity - The cash flow from operating activities for the year-to-date was ¥95,699,591.38, down 36.80% year-on-year[3]. - Net cash flow from operating activities for the first three quarters of 2021 was ¥95,699,591.38, compared to ¥151,419,187.38 in the same period of 2020, reflecting a decline of approximately 36.8%[22]. - Cash inflow from operating activities totaled ¥850,485,045.77 for the first three quarters of 2021, down from ¥927,504,054.95 in 2020, a decrease of about 8.3%[21]. - Cash outflow from operating activities was ¥754,785,454.39 in Q3 2021, compared to ¥776,084,867.57 in Q3 2020, showing a reduction of approximately 2.7%[22]. - The cash and cash equivalents at the end of Q3 2021 stood at ¥152,120,160.68, down from ¥190,161,912.09 at the end of Q3 2020, a decrease of approximately 20%[22]. - The company received cash from investment of ¥1,950,000.00 in Q3 2021, compared to ¥490,000.00 in Q3 2020, marking an increase of approximately 296.3%[22]. - The total cash outflow for financing activities was ¥112,162,946.66 in Q3 2021, compared to ¥77,621,488.74 in Q3 2020, reflecting an increase of about 44.4%[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,618,195,403.38, an increase of 8.69% from the end of the previous year[4]. - The company's total assets increased to ¥1,618,195,403.38 in Q3 2021 from ¥1,488,775,228.11 in Q3 2020, representing a growth of 8.7%[15]. - Total liabilities rose to ¥442,175,973.59 in Q3 2021, up from ¥344,828,414.89 in Q3 2020, indicating a 28.3% increase[15]. - Total current assets as of September 30, 2021, amount to 492,616,806.11 RMB, an increase from 434,941,789.04 RMB at the end of 2020[13]. - Accounts receivable increased to 104,220,192.58 RMB from 95,585,420.88 RMB year-over-year[13]. - Inventory as of September 30, 2021, is 160,464,344.41 RMB, up from 133,452,853.50 RMB at the end of 2020[13]. - Long-term equity investments increased to 37,227,277.09 RMB from 36,288,446.94 RMB year-over-year[13]. - Total liabilities reached $344,828,414.89, reflecting a decrease of $44,961,300.48 from the prior period[26]. - Current liabilities totaled $238,684,433.45, down by $3,766,165.10 compared to the last quarter[25]. - Non-current liabilities decreased to $106,143,981.44, a reduction of $41,195,135.38 from the previous quarter[26]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 18,906[10]. - The largest shareholder, Gao Bo Investment (Hong Kong) Co., Ltd., holds 92,019,200 shares, accounting for 35.39% of total shares[10]. - The total number of shares held by the top 10 shareholders is 162,000,000, representing a significant concentration of ownership[10]. Research and Development - Research and development expenses for Q3 2021 were ¥33,314,053.73, compared to ¥31,676,291.57 in Q3 2020, showing a growth of 5.2%[18]. - The company has not disclosed any new product or technology developments in the current reporting period[12]. Market Performance - The company experienced a significant decline in mask revenue, which decreased by 93.81% compared to the previous year due to market saturation[7]. - Domestic sales of other main products increased by 30.26% year-on-year, indicating a recovery in the domestic market[7]. - The company’s sales expenses increased by 56.75% due to the recovery of marketing activities and an increase in domestic sales personnel[8].